207 related articles for article (PubMed ID: 25085890)
1. Direct inhibition of hypothalamic proopiomelanocortin neurons by dynorphin A is mediated by the μ-opioid receptor.
Pennock RL; Hentges ST
J Physiol; 2014 Oct; 592(19):4247-56. PubMed ID: 25085890
[TBL] [Abstract][Full Text] [Related]
2. Direct inhibition of arcuate proopiomelanocortin neurons: a potential mechanism for the orexigenic actions of dynorphin.
Zhang X; van den Pol AN
J Physiol; 2013 Apr; 591(7):1731-47. PubMed ID: 23318874
[TBL] [Abstract][Full Text] [Related]
3. Differential Desensitization Observed at Multiple Effectors of Somatic μ-Opioid Receptors Underlies Sustained Agonist-Mediated Inhibition of Proopiomelanocortin Neuron Activity.
Fox PD; Hentges ST
J Neurosci; 2017 Sep; 37(36):8667-8677. PubMed ID: 28821664
[TBL] [Abstract][Full Text] [Related]
4. Dynorphin activation of kappa opioid receptor reduces neuronal excitability in the paraventricular nucleus of mouse thalamus.
Chen Z; Tang Y; Tao H; Li C; Zhang X; Liu Y
Neuropharmacology; 2015 Oct; 97():259-69. PubMed ID: 26056031
[TBL] [Abstract][Full Text] [Related]
5. Differential expression and sensitivity of presynaptic and postsynaptic opioid receptors regulating hypothalamic proopiomelanocortin neurons.
Pennock RL; Hentges ST
J Neurosci; 2011 Jan; 31(1):281-8. PubMed ID: 21209213
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels.
Ibrahim N; Bosch MA; Smart JL; Qiu J; Rubinstein M; Rønnekleiv OK; Low MJ; Kelly MJ
Endocrinology; 2003 Apr; 144(4):1331-40. PubMed ID: 12639916
[TBL] [Abstract][Full Text] [Related]
7. Mu-opioid receptor and delta-opioid receptor differentially regulate microglial inflammatory response to control proopiomelanocortin neuronal apoptosis in the hypothalamus: effects of neonatal alcohol.
Shrivastava P; Cabrera MA; Chastain LG; Boyadjieva NI; Jabbar S; Franklin T; Sarkar DK
J Neuroinflammation; 2017 Apr; 14(1):83. PubMed ID: 28407740
[TBL] [Abstract][Full Text] [Related]
8. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
Margolis EB; Hjelmstad GO; Bonci A; Fields HL
J Neurosci; 2003 Nov; 23(31):9981-6. PubMed ID: 14602811
[TBL] [Abstract][Full Text] [Related]
9. Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.
Vaughan CW; Bagley EE; Drew GM; Schuller A; Pintar JE; Hack SP; Christie MJ
Br J Pharmacol; 2003 May; 139(2):362-7. PubMed ID: 12770941
[TBL] [Abstract][Full Text] [Related]
10. Effect of the mu-opioid agonist DAMGO on medial basal hypothalamic neurons in beta-endorphin knockout mice.
Slugg RM; Hayward MD; Ronnekleiv OK; Low MJ; Kelly MJ
Neuroendocrinology; 2000 Oct; 72(4):208-17. PubMed ID: 11070424
[TBL] [Abstract][Full Text] [Related]
11. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
12. DAMGO suppresses both excitatory and inhibitory synaptic transmission in supraoptic neurones of mouse hypothalamic slice preparations.
Honda E; Ono K; Inenaga K
J Neuroendocrinol; 2004 Mar; 16(3):198-207. PubMed ID: 15049850
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology.
Margolis EB; Wallace TL; Van Orden LJ; Martin WJ
PLoS One; 2020; 15(12):e0232864. PubMed ID: 33373369
[TBL] [Abstract][Full Text] [Related]
14. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism.
Madamba SG; Schweitzer P; Siggins GR
J Neurophysiol; 1999 Oct; 82(4):1768-75. PubMed ID: 10515966
[TBL] [Abstract][Full Text] [Related]
15. Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor.
Merg F; Filliol D; Usynin I; Bazov I; Bark N; Hurd YL; Yakovleva T; Kieffer BL; Bakalkin G
J Neurochem; 2006 Apr; 97(1):292-301. PubMed ID: 16515546
[TBL] [Abstract][Full Text] [Related]
16. Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.
Connor M; Schuller A; Pintar JE; Christie MJ
Br J Pharmacol; 1999 Apr; 126(7):1553-8. PubMed ID: 10323586
[TBL] [Abstract][Full Text] [Related]
17. Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response.
Spadoni F; Martella G; Martorana A; Lavaroni F; D'Angelo V; Bernardi G; Stefani A
Synapse; 2004 Mar; 51(3):194-205. PubMed ID: 14666517
[TBL] [Abstract][Full Text] [Related]
18. μ-Opioid inhibition of Ca2+ currents and secretion in isolated terminals of the neurohypophysis occurs via ryanodine-sensitive Ca2+ stores.
Velázquez-Marrero C; Ortiz-Miranda S; Marrero HG; Custer EE; Treistman SN; Lemos JR
J Neurosci; 2014 Mar; 34(10):3733-42. PubMed ID: 24599471
[TBL] [Abstract][Full Text] [Related]
19. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
Schmidt BL; Tambeli CH; Levine JD; Gear RW
Eur J Neurosci; 2002 Mar; 15(5):861-8. PubMed ID: 11906528
[TBL] [Abstract][Full Text] [Related]
20. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
